JEFF EDWARDS – Technical Director
Jeff Edwards is Director of Operations of OBJ as well as Technical
Director and his responsibilities include coordinating the activities
of both the Scientific team and external consulting experts. Jeff
Edwards has previously managed a number of successful international
medical technology projects and their commercial release. He is
experienced in intellectual property, regulatory requirements and
production and has worked in these fields in Australia, USA and Asia.
DR CHRISTOPHER QUIRK – Medical Director
Dr Quirk has been involved for 21 years with both teaching and
research at the University of Western Australia and has worked both in
the public and private sector as a consultant dermatologist.
Previously a director of Xcell Diagnostics, he was involved in the
development of non-invasive diagnostic instrumentation and recently was
principal investigator for 3M Pharmaceuticals, USA in one of their
trials of the recently released Aldara TM ,a cream for the treatment of
basal cell carcinoma. He is a Fellow of the Australasian College of
Dermatologists & a Member of the American Academy of Dermatology.
GLYN DENISON – Non Executive Director
Mr Glyn Denison has over 30 years experience in international business development including 16 years in technology intensive industries, during which time he oversaw company revenues rise from a small base to $250m per year. Glyn Denison has worked in Europe, China and South East Asia and Australia and has extensive networks and contacts across the European medical sector.
|
- Tetracaine
- 5-aminolevulinic acid (5-ALA)
- Hydrocortisone
- Naltrexone Hydrochloride
- Caffeine
- Vaccines

Download
our 2009 Annual Report here
Right-click and save as...
|